According to a recently published systematic review and meta-analysis, patients with rheumatoid arthritis undergoing treatment with tumour necrosis factor inhibitors (TNFi) had a favourable evolution of surrogate markers associated with cardiovascular disease (CVD).

Previous research has shown that inflammation can lead to atherosclerosis and contribute to heart disease, which may ...